Company Filing History:
Years Active: 2021-2024
Title: Yaxi Yang: Innovator in Pharmaceutical Science
Introduction
Yaxi Yang is a prominent inventor based in Shanghai, China, known for his significant contributions to pharmaceutical science. With a total of five patents to his name, Yang has made strides in the development of innovative compounds aimed at treating various diseases.
Latest Patents
Among his latest patents is a histone acetyltransferase (HAT) inhibitor. This invention discloses a compound represented by a general formula, along with its pharmaceutically acceptable salts, stereoisomers, and other variations. The compound is designed for use in treating various HAT-related diseases or conditions. Another notable patent is a heterocyclic amide for inhibiting RIP1 kinase. This invention details a compound that is particularly effective for treating diseases mediated by RIP1 kinase, along with its pharmaceutical applications.
Career Highlights
Yaxi Yang has worked with esteemed organizations such as the Chinese Academy of Sciences and Suzhou Suplead Life Sciences Co., Ltd. His work in these institutions has allowed him to focus on groundbreaking research and development in the field of pharmaceuticals.
Collaborations
Yang has collaborated with notable colleagues, including Bing Zhou and Cheng Luo, who have contributed to his research endeavors.
Conclusion
Yaxi Yang's innovative work in pharmaceutical science, particularly in the development of compounds for treating critical diseases, showcases his dedication to advancing medical research. His contributions continue to impact the field positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.